Oncogenes y Dianas Efectoras
PANCCUN
![Foto de Oncogenes y Dianas Efectoras](/img/uploaded/cfbefccdba02742414c74e77b99a3a7b.jpg)
![Foto de NewYork–Presbyterian Hospital](/img/noimage_org.png)
NewYork–Presbyterian Hospital
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de NewYork–Presbyterian Hospital (1)
2020
-
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Nature Medicine, Vol. 26, Núm. 6, pp. 878-885